Market Cap 2.03B
Revenue (ttm) 1.09B
Net Income (ttm) 62.04M
EPS (ttm) N/A
PE Ratio 40.84
Forward PE 36.59
Profit Margin 5.70%
Debt to Equity Ratio 0.00
Volume 1,243,000
Avg Vol 1,871,170
Day's Range N/A - N/A
Shares Out 85.15M
Stochastic %K 57%
Beta 1.34
Analysts Sell
Price Target $22.62

Latest News on PGNY

Progyny: Rating Downgrade On Uncertain Growth Outlook

Nov 26, 2024, 7:54 AM EST - 3 months ago

Progyny: Rating Downgrade On Uncertain Growth Outlook


Progyny: After A Terrible Year, I'm Out (Rating Downgrade)

Nov 17, 2024, 11:47 PM EST - 3 months ago

Progyny: After A Terrible Year, I'm Out (Rating Downgrade)


Progyny, Inc. (PGNY) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:15 PM EST - 3 months ago

Progyny, Inc. (PGNY) Q3 2024 Earnings Call Transcript


Progyny, Inc. Announces Third Quarter 2024 Results

Nov 12, 2024, 4:02 PM EST - 3 months ago

Progyny, Inc. Announces Third Quarter 2024 Results


Progyny: Poor Year Raises Concerns For Future (Downgrade)

Oct 15, 2024, 3:00 PM EDT - 4 months ago

Progyny: Poor Year Raises Concerns For Future (Downgrade)


Top 3 Health Care Stocks That May Explode This Month

Sep 23, 2024, 7:13 AM EDT - 5 months ago

Top 3 Health Care Stocks That May Explode This Month

INDV MRNA